ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 172

Prospective Assessment of Carotid Intima Media Thickness in Relation to Activity of the Disease in Patients with Rheumatoid Arthritis

Bozena Targonska-Stepniak1, Mariusz Piotrowski1, Robert Zwolak2 and Maria Majdan3, 1Rheumatology and Connective Tissue Diseases, Medical University of Lublin, Poland, Lublin, Poland, 2Rheumatologyand Connective Tissue Diseases, Medical University of Lublin, Lublin, Poland, 3Department of Rheumatology and Connective Tissue Diseases, Medical University in Lublin, Poland, Lublin, Poland

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Atherosclerosis, Disease Activity, intima medial thickness, rheumatoid arthritis (RA) and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Imaging of Rheumatic Diseases Poster I: Ultrasound, Optical Imaging and Capillaroscopy

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is a chronic, inflammatory disease that is complicated by accelerated atherosclerosis associated with the risk of adverse cardiovascular (CV) events and death. Traditional risk factors do not fully explain the increased CV risk in RA. RA-related inflammation that is responsible for joint damage may be implicated in the development of accelerated atherosclerosis. Carotid intima-media thickness (cIMT) has been approved as a surrogate marker of early atherosclerosis. The goal of the study was to assess (1) prospectively cIMT in patients with established RA, (2) the relationship between  cIMT and RA activity estimated by clinical examination and ultrasonography of joints.   

Methods: The study group consisted of 40 consecutive RA patients, 33 (82,5%) female and 7 male (17,5%) with the mean (SD) age 52.3 (9.8) (range 24-68) and disease duration 18.6 (9.6) years (range 6.5-45). The assessment of cIMT was performed twice, in the space of six years (the initial in 2008 and consecutive in 2014) and was determined by high-resolution B-mode ultrasonography. The activity of RA was estimated by clinical examination [with disease activity score in 28 joints (DAS28)] and ultrasonography of joints (synovial hypertrophy in 24 small joints). At the consecutive visit, high disease activity was observed in 7 (17,5%) patients, and low RA activity or remission in 23 (57,5%). Most patients, 35 (87,5%) were treated with biological disease modifying antirheumatic drugs (DMARDs) during the six years period and only synthetic DMARds were used in 5 (12,5%) patients.     

Results: The mean (SD) cIMT value was significantly greater at consecutive than initial assessment [0.86 (0.45) vs 0.75 (0.13) mm, p= 0.02]. The number of RA patients with advanced atherosclerosis (presence of plaques) increased from 6 (15%) at the initial to 9 (22,5%) at the consecutive assessment (NS). The number of patients without atherosclerosis (cIMT < 0.6 mm) deceased from 4 (10%) at the initial to 3 (7,5%) at the consecutive assessment. The value of cIMT correlated positively with the age of patients (p< 0,001) and the two cIMT values correlated with each other (p=0,01). There was no correlation between cIMT value and parameters of RA activity (DAS28 and synovial hypertrophy in ultrasonography). There was a positive correlation between DAS28 value and the number of joints with synovial hypertrophy assessed in ultrasonography.

Conclusion: During the six-years course of established RA, progression of atherosclerosis was observed, estimated by significantly greater mean cIMT value, as well as increased number of patients with atherosclerotic plaques. Progressive atherosclerosis occurred in spite of intensive RA treatment, including biological DMARDs. The process seems to be dependent on the age and was not correlated with the current RA joint activity.


Disclosure: B. Targonska-Stepniak, None; M. Piotrowski, None; R. Zwolak, None; M. Majdan, None.

To cite this abstract in AMA style:

Targonska-Stepniak B, Piotrowski M, Zwolak R, Majdan M. Prospective Assessment of Carotid Intima Media Thickness in Relation to Activity of the Disease in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/prospective-assessment-of-carotid-intima-media-thickness-in-relation-to-activity-of-the-disease-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prospective-assessment-of-carotid-intima-media-thickness-in-relation-to-activity-of-the-disease-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology